BridgeMD
New treatment option for Stroke, Acute
Official title Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia.
ClinicalTrials.gov ID: NCT06123650
What this study is testing
- What it's testing
- BACKGROUND: Dysphagia is one of the most life-threatening stroke complications. Dysphagic stroke patients are at increased risk of aspiration pneumonia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 49 to 65
You may be able to join if
- All the patients were diagnosed of stroke oropharyngeal dysphagia by a neurologist. Sever to moderate dysphagia (GUSS 0-14).
- Severity of stroke ranged from mild to moderate according to NIHSS score (NIHSS less than or equal 16).
- Patients' age ranged from 49 to 65 years old.
- Patients had the ability to understand and follow instructions.
- Patients were able to sit in upright position.
You likely can't join if
- History of previous stroke.
- History of any swallowing problem.
- History of any head and neck surgery or tumor that causes swallowing dysfunction.
- Any lung disease or pneumonia on admission.
- Patients with cognitive deficits or disturbed conscious level.
- Patients on mechanical ventilator.
See the full eligibility criteria
- All the patients were diagnosed of stroke oropharyngeal dysphagia by a neurologist. Sever to moderate dysphagia (GUSS 0-14).
- Severity of stroke ranged from mild to moderate according to NIHSS score (NIHSS less than or equal 16).
- Patients' age ranged from 49 to 65 years old.
- Patients had the ability to understand and follow instructions.
- Patients were able to sit in upright position.
- History of previous stroke.
- History of any swallowing problem.
- History of any head and neck surgery or tumor that causes swallowing dysfunction.
- Any lung disease or pneumonia on admission.
- Patients with cognitive deficits or disturbed conscious level.
- Patients on mechanical ventilator.
- Patients with sensory or global aphasia.
The study team makes the final eligibility decision.
Where it's taking place
- Giza, Giza Governorate, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 49 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Giza, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.